Daily Dose - Aug 25th, 2026
Daily Dose |
View online
August 25, 2026
Cellares to downsize following Bristol Myers Squibb decision to end partnership
The loss is forcing the automated cell therapy manufacturer to resize, despite doubling the number of customers in 2026.
Read More
Cambrex clears regulatory inspections for commercial API manufacturing
The High Point, North Carolina facility can now manufacture approved active pharmaceutical ingredients for the U.S., Japan, and Australia.
Read More
Hovione adds commercial-scale tablet manufacturing capacity at Portugal site
The €40 million expansion increases batch tableting capacity and creates 50 jobs at the CDMO’s Loures production center.
Read More
Sponsored
Unlocking Pharmaceutical Wastewater Capacity Without Construction
Learn how oxygen-enriched biological treatment helps pharmaceutical manufacturers unlock up to 50% additional wastewater treatment capacity, improve oxygen transfer efficiency, and maximize the performance of existing wastewater treatment assets.
Download Now
